Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy

Página do item simplificado
dc.creatorLarissa Aparecida Corrêavieira
dc.creatorAmanda Gomes de Menêses
dc.creatorPriscila de Sousa Maggi Bontempo
dc.creatorGiovana Paula Rezende Simino
dc.creatorElaine Barros Ferreira
dc.creatorEliete Neves da Silva Guerra
dc.creatorPaula Elaine Diniz Dos Reis
dc.date.accessioned2024-02-27T20:38:28Z
dc.date.accessioned2025-09-08T23:42:11Z
dc.date.available2024-02-27T20:38:28Z
dc.date.issued2022
dc.format.mimetypepdf
dc.identifier.doi10.1590/1980-220x-reeusp-2022-0173en
dc.identifier.issn1980220X
dc.identifier.urihttps://hdl.handle.net/1843/64826
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofRevista da Escola de Enfermagem da USP
dc.rightsAcesso Aberto
dc.subjectRadiodermatitis
dc.subjectRadiotherapy
dc.subjectBreast Neoplasms
dc.subjectMedical Oncology
dc.subjectNursing
dc.subjectRadiation Dose Hypofractionation
dc.subject.otherRadiodermatitis
dc.subject.otherRadiotherapy
dc.subject.otherBreast Neoplasms
dc.subject.otherOncology
dc.subject.otherNursing
dc.subject.otherRadiation Dose Hypofractionation
dc.titleIncidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy
dc.title.alternativencidencia de radiodermatitis en pacientes con cáncer de mama durante la radioterapia hipofraccionada
dc.typeArtigo de periódico
local.citation.epage9
local.citation.issuee20220173
local.citation.spage1
local.citation.volume56
local.description.resumoObjective: To analyze the incidence, dose of occurrence, grade, severity, and associated risk factors for the development of radiodermatitis, by area of the irradiated breast, in women with breast cancer, during hypofractionated radiotherapy. Method: Observational, prospective, and longitudinal study, according to the guidelines of the Strengthening the Reporting of Observational studies in Epidemiology, carried out between May 2019 and May 2021. Results:A total of 104 women participated in the study, and 73.1% (95%CI: 64–82) developed signs of radiodermatitis during treatment. The majority (63.5%, 95%CI: 54–73) developed erythema in the axillary region with about 36.5 Grays. Women with large breasts and statin users are more likely to develop radiodermatitis. However, women with Phototype III skin color classification (light brown skin) are less likely to develop radiodermatitis, with skin color being a protective factor. Conclusion: The incidence of radiodermatitis in women with breast cancer during hypofractionated radiotherapy is significant. Therefore, the development of protocols for the management of this radiotoxicity is suggested, considering the cumulative dose and associated risk factors
local.publisher.countryBrasil
local.publisher.departmentENF - DEPARTAMENTO DE ENFERMAGEM BÁSICA
local.publisher.initialsUFMG
local.url.externahttps://doi.org/10.1590/1980-220X-REEUSP-2022-0173en

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
Incidence of radiodermatitis in breast cancer patients pdfa.pdf
Tamanho:
4.02 MB
Formato:
Adobe Portable Document Format
Baixar

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição:
Baixar

Coleções

Artigo de Periódico

Logo UFMG